Genetics, Vol. 162, 1703-1724, December 2002, Copyright © 2002

The fruitless Gene Is Required for the Proper Formation of Axonal Tracts in the Embryonic Central Nervous System of Drosophila

Ho-Juhn Song1,a, Jean-Christophe Billeter2,b, Enrique Reynaud3,c, Troy Carlob, Eric P. Spana4,d, Norbert Perrimond, Stephen F. Goodwin2,b, Bruce S. Bakerc, and Barbara J. Taylora
a Department of Zoology, Oregon State University, Corvallis, Oregon 97331-2914,
b Department of Biology, Brandeis University, Waltham, Massachusetts 02454-9110,
c Department of Biological Sciences, Stanford University, Stanford, California 94305-5020
d Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115

Corresponding author: Barbara J. Taylor, 3029 Cordley Hall, Oregon State University, Corvallis, OR 97331-2914., taylorb{at}bcc.orst.edu (E-mail)

Communicating editor: T. SCHÜPBACH


*  ABSTRACT
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

The fruitless (fru) gene in Drosophila melanogaster is a multifunctional gene that has sex-specific functions in the regulation of male sexual behavior and sex-nonspecific functions affecting adult viability and external morphology. While much attention has focused on fru's sex-specific roles, less is known about its sex-nonspecific functions. We have examined fru's sex-nonspecific role in embryonic neural development. fru transcripts from sex-nonspecific promoters are expressed beginning at the earliest stages of neurogenesis, and Fru proteins are present in both neurons and glia. In embryos that lack most or all fru function, FasII- and BP102-positive axons have defasciculation defects and grow along abnormal pathways in the CNS. These defects in axonal projections in fru mutants were rescued by the expression of specific UAS-fru transgenes under the control of a pan-neuronal scabrous-GAL4 driver. Our results suggest that one of fru's sex-nonspecific roles is to regulate the pathfinding ability of axons in the embryonic CNS.


THE fruitless (fru) gene has a prominent role in developing the potential for male sexual behavior as well as adult viability and normal external morphology (ITO et al. 1996 Down; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down; ANAND et al. 2001 Down; LEE and HALL 2001 Down; LEE et al. 2001 Down). fru's functional complexity is reflected in the structural complexity of the locus. The fru gene encodes a large set of sex-specific and sex-nonspecific transcripts generated by differential promoter usage and alternative splicing at the 5' and 3' ends (ITO et al. 1996 Down; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down). fru transcripts from four different promoters, P1, P2, P3, and P4, encode closely related BTB/POZ (Broad complex, Tramtrack, and Bric-a-brac/ Poxvirus and Zinc finger)-Zn finger (ZnF) proteins, which likely act as transcription factors (ITO et al. 1996 Down; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; LEE et al. 2000 Down; USUI-AOKI et al. 2000 Down; ANAND et al. 2001 Down).

The male-specific behavioral functions of fru depend on transcripts produced from the P1 promoter that are sex-specifically spliced (ITO et al. 1996 Down; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down; ANAND et al. 2001 Down). In males a default 5' acceptor splice site is used, whereas in females, the Transformer (Tra) and Transformer-2 (Tra-2) proteins direct splicing to a second downstream acceptor site (RYNER et al. 1996 Down; HEINRICHS et al. 1998 Down; USUI-AOKI et al. 2000 Down). In both sexes, alternative splicing at the 3' end leads to the generation of three types of P1 transcripts, each with a different pair of ZnF domains (GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down). A consequence of the sex-specific splicing of P1 primary transcripts is the generation of a set of P1 transcripts in males, which upon translation produce a family of proteins with an amino-terminal extension preceding the BTB/POZ domain and a set of P1 transcripts in females, which are not translated (ITO et al. 1996 Down; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; LEE et al. 2000 Down; USUI-AOKI et al. 2000 Down). The male-specific P1 transcripts are translated into male-specific Fru proteins (FruM), which are expressed in nearly 2000 neurons in the pupal and adult central nervous system (CNS) and play an important role in male sexual behavior and in the formation of a male-specific abdominal muscle known as the muscle of Lawrence (ITO et al. 1996 Down; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; LEE et al. 2000 Down; USUI-AOKI et al. 2000 Down; ANAND et al. 2001 Down). Recently, it has been shown that the FruM proteins are required for the presence of the serotonin neurotransmitter in a set of abdominal neurons that innervate the masculine internal genitalia and mediate aspects of male fertility (LEE and HALL 2001 Down; LEE et al. 2001 Down).

The products of the P2, P3, and P4 fru promoters differ from those of the P1 promoter in their spatial patterns of expression, their protein coding sequences, and their functions (RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; ANAND et al. 2001 Down). Transcripts from the P2, P3, and P4 promoters encode a small amino-terminal extension of a few amino acids preceding the common BTB/POZ domain compared to the 101 amino-terminal motif found in the P1-derived male-specific proteins (S. F. GOODWIN, L. C. RYNER, T. CARLO, M. FOSS, J. C. HALL, B. J. TAYLOR and B. S. BAKER, unpublished results). In situ hybridization using a probe from the common coding region of fru, which detects all or most of the known fru transcripts, shows that fru transcripts from non-P1 promoters are ubiquitously expressed in the adult CNS and in particular subsets of nonneuronal tissues during larval and pupal development of both adult male and female flies (RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; LEE et al. 2000 Down). Anti-Fru antibodies, which recognize the common region of Fru proteins, confirm that these fru RNAs are translated in both sexes in the CNS and nonneuronal tissues (LEE et al. 2000 Down). Genetic analysis of fru mutants shows that mutants lacking the P3 and/or P4 transcript classes die at the pupal stage, suggesting that the expression of a subset of fru transcripts is essential for adult viability (RYNER et al. 1996 Down; ANAND et al. 2001 Down). In some fru mutant genotypes, adult escapers show a variety of defective external phenotypes, indicating that these transcripts likely have some function in the development of these adult structures (ANAND et al. 2001 Down).

To gain a better understanding of the role of fru's P2, P3, and P4 transcripts in development, we determined the expression pattern of fru RNAs and proteins in the embryonic CNS. In this article, we show that fru RNAs and proteins are produced in a dynamic pattern during embryogenesis and are widely expressed in the developing embryonic CNS. Neuronal precursors as well as neurons and glial cells express Fru proteins. The embryonic CNS is an important model system for defining how specific genes govern neuronal identity and the process of axonal pathfinding necessary for the formation of proper neuronal connections (reviewed in GOODMAN and DOE 1993 Down; GOODMAN 1996 Down; TEAR 1999 Down). The main axonal tracts in the ventral nerve cord of the fruit fly embryonic CNS consist of two bilaterally symmetrical longitudinal connectives with a pair of commissures, anterior and posterior, that cross the midline in each segment (GOODMAN and DOE 1993 Down). The proper formation of this longitudinal and commissural axon scaffold is complex and involves the directed growth of axonal processes from interneurons and motoneurons in specific fascicles within the CNS (e.g., reviewed in TEAR 1999 Down and RUSCH and VAN VACTOR 2000 Down). Diffusible molecules secreted from cells along the midline are one of the mechanisms involved in attracting or repulsing specific axons (GUTHRIE 1999 Down; reviewed in TEAR 1999 Down; BROSE and TESSIER-LAVIGNE 2000 Down). Axons, as they grow through the CNS, selectively fasciculate and defasciculate to find their appropriate synaptic targets (TEAR 1999 Down; RUSCH and VAN VACTOR 2000 Down).

Analyses of fru mutants, in which specific subsets of transcripts are disrupted or in which no fru transcripts are made, revealed that Fasciclin II (FasII)-positive axons had abnormal trajectories, as did axons producing other longitudinal and commissural tracts in the CNS. Our findings suggest that fru transcripts are needed in the embryonic CNS for the formation of the wild-type pattern of axonal tracts. The defects in the FasII-positive and BP102-positive axonal tracts found in fru mutants were rescued by the expression of specific fru isoforms under the control of the pan-neuronal sca-GAL4 driver, which has a pattern of expression similar to that of Fru proteins. In contrast, these mutant phenotypes were not rescued by fru transgene expression driven by the elav-GAL4 driver, which is expressed exclusively in postmitotic neurons. The neurons that pioneer the FasII fascicles express markers appropriate to their wild-type identity in fru mutants. Our analysis suggests that fru's primary function during neurogenesis is the regulation of fasciculation and defasciculation processes involved in the growth of neuronal axons along their wild-type pathway through the CNS.


*  MATERIALS AND METHODS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Fly stocks and crosses:
Canton-S flies were used as the wild-type genotype. The following fru mutant alleles were used: fru3; fru4; frusat; In(3R)fru1 (fru1); Df(3R)ChaM5 (ChaM5); Df(3R)fruw24 (fruw24); In(3R) fruw27 (fruw27); Df(3R)frusat15 (frusat15); Df(3R)fru4-40 (fru4-40); In(3R)fruw12 (fruw12); Df(3R)P14 (P14) (CASTRILLON et al. 1993 Down; ITO et al. 1996 Down; RYNER et al. 1996 Down; ANAND et al. 2001 Down). fru mutant alleles were maintained over either TM6B, Tb, Hu or TM3, Sb, P[ftz-lacZ]. To label midline glial cells in fru mutants (see below), the P element in the enhancer-trap line AA142 (SCHOLZ et al. 1997 Down; Bloomington Stock Center) was recombined onto the frusat15 and fruAJ96u3 chromosomes. Fly stocks were maintained at room temperature on an agar, sucrose, cornmeal, and yeast medium supplemented with 0.1% nipagin (p-hydroxybenzoic acid methyl ester; Sigma, St. Louis) for mold inhibition.

A deficiency, Df(3L)XDI98 (65A02-65E1), was used to examine the phenotypes associated with the non-fru inversion breakpoint, at 65C-D, of the fruw12 chromosome. fruw12/Df(3L) XDI98 mutants were fully viable, fertile, and morphologically normal adults (n = 10 male; n = 10 female). Deficiency heterozygous males did not show courtship chaining behaviors, a typical fru mutant phenotype (n = 20, 10 males each group). Due to the similarity of phenotypes, a spread mutant allele (sprd05284; SPRADLING et al. 1999 Down; Bloomington Stock Center) was used in complementation tests with various fru mutations. There were no adult sprd05284/fruw24 survivors, indicating that large fru deficiencies uncover the sprd locus (0/36 control siblings). However, sprd05284 trans-heterozygotes with other fru alleles were fully viable with a normal wing phenotype (sprd05284/fru4-40, n = 61; sprd05284/fruw12, n = 30; sprd05284/fruAJ96u3, n = 24) and did not form male-male courtship chains (sprd05284/fru4-40, n = 20; sprd05284/fruw12, n = 8; sprd05284/fruAJ96u3, n = 9).

Generation and molecular characterization of the fruAJ96u3 deficiency:
The AJ96w+ P element (SPANA and DOE 1996 Down) was mapped by isolating flanking genomic sequences using inverse PCR followed by sequencing (YEO et al. 1995 Down). These query sequences were used for BLAST homology searches against the Drosophila genome and mapped to genomic sequences that include the fru locus (accession no. AE003722; FLYBASE 1999 Down). To create new fru mutations, excisions of the AJ96w+ P element were induced by standard techniques (ROBERTSON et al. 1988 Down). One lethal excision out of 56 w- revertant lines was recovered. The molecular limits of the fruAJ96u3 deficiency were determined by a combination of Southern blot analysis and genomic PCR using oligo primers obtained from plasmid subclones from across the fru region and flanking sequences (data not shown). The exact molecular locations of the deficiency breakpoints were determined by using oligo primers, flanking these sequences, to PCR amplify fragments that contain sequences around the breakpoints. These PCR fragments were sequenced and compared to the published sequences for this region.

Lethal phase, phenotypic, fertility, and behavioral analysis of fruAJ96u3 mutant animals:
To characterize the fruAJ96u3 mutation, trans-heterozygotes between fruAJ96u3 and other fru alleles were examined. In those crosses in which adult fru trans-heterozygotes did not survive, the pupal stage at which the fru mutant combination died was determined from aged collections of white prepupae and by staging based on BAINBRIDGE and BOWNES 1981 Down. For genotypes that reached late stages of pupal development, the pupal case was dissected to allow the animals to emerge.

For sterility tests, virgin males were collected a few hours after eclosion and housed as groups of 8–10 males in food vials. After 4 days, individual males were mated with 2 or 3 Canton-S virgin females and the vials were examined after 7 days for the presence of larvae and/or pupae. To determine whether males would form courtship chains (VILLELLA et al. 1997 Down), males were collected after eclosion and aged alone for 3–4 days. Eight males of the same genotype were then put together in a food vial and observed in the late afternoon or early evening for the presence of male courtship chains with >3 males courting during a 1-hr period over 3–4 days.

Embryonic immunohistochemistry:
Timed embryo collections were staged by morphological criteria (CAMPOS-ORTEGA and HARTENSTEIN 1997 Down) and prepared for immunohistochemistry according to PATEL 1994 Down. The following primary antibodies were used (except where noted, these antibodies were a gift from N. Patel) to label neurons and glial cells: anti-Fasciclin II (1D4, 1:5; GRENNINGLOH et al. 1991 Down), mab22C10 (1:200; FUJITA et al. 1982 Down), anti-Elav (9F8, 1:30; O'NEILL et al. 1994 Down), mabBP102 (1:20; SEEGER et al. 1993 Down), anti-Repo (1:100; a gift of A. Travers; HALTER et al. 1995 Down), anti-Engrailed/Invected (4D9, 1:10; PATEL et al. 1989 Down), and anti-Odd-skipped (1:200; a gift from J. Skeath; SPANA et al. 1995 Down). To label fru-positive cells, rat anti-FruCOM (1:500; LEE et al. 2000 Down), rat anti-FruBTB' (1:500; this study, see below), rat anti-FruA' (1:500; this study), and rat anti-FruC' (1:500; this study) were used. In all experiments, embryos were labeled with anti ß-galactosidase antibodies (1:10,000; Cappel, Durham, NC) to distinguish fru mutant embryos (ß-galactosidase negative) from control sibling embryos (ß-galactosidase positive).

For detection of primary antibodies, we used secondary antibodies, which were directly conjugated with horseradish peroxidase (Jackson ImmunoResearch Laboratories, West Grove, PA), with alkaline phosphatase (AP; Jackson ImmunoResearch), or with the fluorochromes Alexa-594, Alexa-488, or Alexa-395 (Molecular Probes, Eugene, OR). For anti-Repo labeling, a biotinylated secondary antibody was used followed by incubation with the ABC reagent (Vector Laboratories, Burlingame, CA). For some double-label experiments, colorimetric visualization of diaminobenzidine (Sigma) was nickel enhanced (PATEL 1994 Down). Enzymatic processing of alkaline phosphatase used NBT/X-phosphatase (Boehringer Mannheim, Indianapolis) in AP reaction buffer (0.1 M NaCl, 0.1 M Tris-HCl, pH 9.5, 0.05 M MgCl2, 0.1% Tween 20; PATEL 1994 Down). To improve the signal obtained from the anti-Fru antibodies, we used the tyramide-based signal amplification kit (New England Nuclear, Boston) prior to staining for AP.

Labeled whole-mount and filleted embryos were viewed and photographed with a Sony DKC-5000 digital camera under differential interference contrast optics, using an Olympus Vanox-TX microscope. For certain double- or triple-labeling experiments, fluorescently labeled embryos were viewed on a TCS-Leica confocal microscope. Composite images were assembled in Adobe Photoshop 5.0.

In situ hybridization of embryos:
Single-strand antisense and sense riboprobes for in situ hybridization were prepared as previously described (RYNER et al. 1996 Down; GOODWIN et al. 2000 Down). The following antisense riboprobes were used: the common coding region probe (antisense-Com, nucleotides (nt) 2785–3612, GenBank accession no. U72492), the BTB domain region probe (nt 2075–2422, GenBank accession no. U72492), the P1-promoter-derived sex-specific probe (probe P1.S, nt 160,236–159,918, accession no. AE003722), the P2 5' end probe (nt 121,168–121,101 plus 120,967–120,936; AE0037222.2), the P3 5' end probe (nt 95,033–94,958, accession no. AE003722), the P4 5' end probes (nt 61,666–61,268, accession no. AE003722), and the Zn finger motif probes A (nt 1743–2294, accession no. D84437), B (nt 37,721–37,479, accession no. AE003722), and C (nt 3872–4114, GenBank accession no. U72492).

The protocols for fixation and in situ hybridization were according to BROADUS and DOE 1995 Down except that RNase treatment (1 mg/ml) was included after hybridization to minimize nonspecific binding of the riboprobe. To visualize the signal, embryos were incubated in dilute anti-digoxigenin-AP (1:2000) and reacted for AP (BROADUS and DOE 1995 Down). Embryos were mounted in 70% glycerol and viewed as either whole-mount or dissected preparations.

Generation of transformants:
Six different UAS-fru constructs were made from fru cDNAs subcloned in pBluescript KS (RYNER et al. 1996 Down; S. F. GOODWIN, L. C. RYNER, T. CARLO, M. FOSS, J. C. HALL, B. J. TAYLOR and B. S. BAKER unpublished results). These constructs all have a minimal 5'-untranslated region (UTR) and were subcloned into a pUAST vector (BRAND and PERRIMON 1993 Down; VAN ROESSEL and BRAND 2000 Down). The UAS-fruA, UAS-fruB, and UAS-fruC constructs all started at the same 5' EcoRI site (128,354, accession no. AE003722.2) and included identical 5'-UTR, BTB, and common fru coding sequences but different 3' end sequences. The UAS-fruA construct contains a 3-kb EcoRI fragment of fru cDNA no. 7 (L. C. RYNER, personal communication; the A 3' end terminates at nt 40563, accession no. AE003722.2). The UAS-fruB construct contains a 4.5-kb EcoRI-XbaI fragment from a fru cDNA no. 25 (L. C. RYNER, personal communication; the B 3' terminates at nt 36684, accession no. AE003722.2). The UAS-fruC construct contains a 3.6-kb EcoRI-KpnI fragment of the female cDNA no. 1 (GenBank accession no. U72492, nt 1763–5409). The UAS-fruMA, UAS-fruMB, or UAS-fruMC constructs all have the same 5' sequences, which encode the 101 male-specific amino terminus and the BTB domain derived from fru male cDNA nos. 5-19 (L. C. RYNER, personal communication). This cDNA was truncated at the 3' end and subcloned into pMartini (a gift from N. Brown) as a SacI-PvuI fragment. The final constructs were generated via a three-way ligation into the pUAST vector. The 5' sequences (1.2-kb EcoRI-PvuI fragment) were ligated to a 1.948-kb PvuI-EcoRI fragment (A 3' end; fru cDNA no. 7; L. C. RYNER, personal communication), a 1.98-kb PvuI-HindIII fragment (B' end; fru cDNA no. 25; L. C. RYNER, personal communication), or a 1.98-kb PvuI-KpnI (C 3' end; nt 2824–5409, GenBank accession no. U72492). These constructs would encode Fru proteins like those from P4 transcripts and similar to those from P2 and P3 transcripts, which have N-terminal extensions of a few more amino acids than P4 Fru proteins (S. F. GOODWIN, L. C. RYNER, T. CARLO, M. FOSS, J. C. HALL, B. J. TAYLOR and B. S. BAKER, unpublished results).

The pUAST vectors also contained a mini-white reporter gene and the final transgene constructs were introduced into the Df(1)yw parental strain by germline transformation as described in RUBIN and SPRADLING 1982 Down. Transgene constructs (300 µg/ml) were coinjected with the helper plasmid pUCHS{Delta}2-3 (100 µg/ml). The chromosomal location of 3–10 transformant lines was determined. If a transformant line contained two insertions on different chromosomes, the transgenes were segregated and treated as independent lines. Each UAS-fru construct was crossed into a fruW12 or frusat15 mutant background and balanced over TM3, Sb, and P[ftz-lacZ]. At least two independent lines for each construct were tested and analyzed.

To express these various UAS-fru constructs in the CNS, lines containing scabrous-GAL4 (sca-GAL4) and embryonic lethal abnormal vision-GAL4 C155 (elav-GAL4; LIN and GOODMAN 1994 Down; Bloomington Stock Center) transgenes were crossed into a fruW12 or frusat15 mutant background. The scabrous sequences in the transgenic construct drive pan-neuronal expression of GAL4 from neuroblasts through neurons (KLAES et al. 1994 Down; see below) and the elav sequences in this transgenic construct drive expression in postmitotic neurons (LIN and GOODMAN 1994 Down). Crosses between a GAL4 line and a UAS-fru line generated the fru mutant embryos in which one of the fru isoforms was expressed in the CNS and peripheral nervous system (PNS). To distinguish fru mutant embryos from control siblings, all embryos were labeled with anti-ß-galactosidase (1:10,000; Cappel), which permitted unlabeled fru mutant embryos to be distinguished from labeled control siblings, expressing the lacZ marker.

Generation of Fru antibodies:
For the glutathione S-transferase (GST) fusion constructs, coding regions for the fru BTB domain and alternative ZnF A and C (Fig 1) were generated by PCR. Oligonucleotide pairs containing sites for in-frame directional cloning in the pGEX-4T-1 vector (Pharmacia, Piscataway, NJ) were designed for BTB and each unique ZnF sequence. DNA was amplified from fru cDNA clones (primer sequences for BTB domain are BTB-1-For, GGG GGA ATT CAT GGA CCA GCA ATT CTG CTT 3'; BTB-115-Rev, GGG GGC TCG AGC TAG TTG TTA TCT GTG AGA 3'; those for A form ZnF domain are A-For, 5' CCG GAA TTC CAG CAG CGC CCG CCA CC 3'; A-Rev, 5' GCC GCT CGA GCG GGA TGG GCT GCA CTT GGG C; and those for C form ZnF domain are C-For, 5' CCG GAA TTC CGC GTC AAG TGT TTT AAC ATT AAG C 3'; C-Rev, 5' CCG CTC GAG GTT TGC TTG ATT CTT GGT TAC TTA G 3'), digested with EcoRI and XhoI enzymes, and cloned into the polylinker of the pGEX-4T-1 vector. Individual recombinant clones were validated by sequencing.



View larger version (28K):
In this window
In a new window
Download PPT slide
 
Figure 1. The molecular map of the fru locus. The insertion sites of the P elements, fru2, fru3, fru4, frusat, and AJ96w+, are indicated by triangles (ITO et al. 1996 Down; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; ANAND et al. 2001 Down; this article). The AJ96w+ P element is located 3 kb from the 3' end of the fru locus (this article). The fru breakpoints of the inversion alleles fru1 and fruw12 are shown on the genomic map, but the inversion allele fruw27 is more complex with the relevant break somewhere between P2 and P3, since no P2 transcripts are detected by reverse transcriptase-PCR (ANAND et al. 2001 Down). The limits of relevant fru deficiencies, including the Df(3R)fruAJ96u3 described in this article, are delineated with thick black lines to represent deleted sequences and dashed lines to represent breakpoints mapped to the relevant restriction fragment (ANAND et al. 2001 Down; this article). fru exons are positioned on the genomic map. Four promoters (P1–P4) are distributed throughout the locus and there are three alternative 3' ends (A, B, and C). Each 3' end encodes a different pair of ZnF domains (GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down; S. F. GOODWIN, L. C. RYNER, T. CARLO, M. FOSS, J. C. HALL, B. J. TAYLOR and B. S. BAKER, unpublished results). The P1 promoter produces primary transcripts that are spliced in females specifically by the TRA and TRA-2 proteins binding to three repeats located in the S exon. These transcripts also contain the BTB domain and other common exons (C1–5) and are spliced alternatively to one of the three different 3' ends (RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down). Transcripts derived from the other three promoters, P2, P3, and P4, contain the BTB and common exons but it is not known whether these transcripts utilize all of the possible alternative 3' ends. Therefore, the full extent of transcript complexity from these promoters is not known (RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down; ANAND et al. 2001 Down; S. F. GOODWIN, L. C. RYNER, T. CARLO, M. FOSS, J. C. HALL, B. J. TAYLOR and B. S. BAKER, unpublished results).

Fusion proteins were purified according to SMITH 1993 Down. These fusion proteins were SDS-PAGE purified and not proteolytically cleaved from the GST so that the whole GST-ZINC FINGER or GST-BTB peptides were used as the immunogen. These materials were injected into rats using a 77-day protocol. In brief, 750 µg of purified protein was injected into each animal with complete Freund's adjuvant, followed by three 750-µg immunizations (boosters) using incomplete Freund's adjuvant. Serum was collected by exsanguinations at the end of the protocol. Titer and specificity of the antibodies were assayed by Western blots of the recombinant protein (data not shown). Harvested polyclonal antisera against the fru BTB domain and the A and C forms of the ZnF domain hereafter are named as anti-FruBTB', anti-FruA', and anti-FruC', respectively.

Statistics:
The frequency of defective embryos in various fru mutant and wild-type embryos was analyzed statistically by one-way ANOVA (SAS program version 6.12; SAS Institute) and post hoc analyzed by Tukey HSD comparisons or by two-sample t-test (SAS program version 6.12).


*  RESULTS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Isolation and characterization of a new fru null mutation:
The AJ96w+ P element, which labels a pair of midline neurons in each segment of the embryonic CNS, was mapped molecularly to ~3 kb downstream of the 3' end of the fru locus (Fig 1; MATERIALS AND METHODS; SPANA and DOE 1996 Down). Homozygous AJ96w+ males did not have a fru mutant phenotype as they were fertile (31/32 males, each paired with two or three virgin Canton-S females) and failed to form male-male courtship chains (six tests of 8 males each; total n = 48).

We mobilized this P element and generated a deficiency line, Df(3R)AJ96U3 (fruAJ96u3). This deletion extends from sequences within the AJ96w+ P element to sequences between the P3 and P4 promoters, thus deleting all fru common coding sequences (Fig 1; see MATERIALS AND METHODS). As the smallest available deficiency of the fru locus, it appears to remove fru and only one other putative open reading frame located between the 3' end of the fru locus and the AJ96w+ P element (29,144–27,188 bp, accession no. AE003722; FLYBASE 1999 Down). Phenotypic analysis confirmed that fruAJ96u3 is a fru null allele. fruAJ96u3 trans-heterozygotes with hypomorphic fru alleles were fully viable (Table 1A) but were sterile (0/18 fertile fru4-40/fruAJ96u3 males; 0/18 fertile fru4/fruAJ96u3 males). fru trans-heterozygotes with strong fru alleles, such as fruw27/fruAJ96u3, survived to late pupal stages and often would emerge if dissected out of the pupal case, but had striking visible external defects, such as uninflated wings or malformed leg joints (Table 1C and Table 1D; see also ANAND et al. 2001 Down). By comparison, fruAJ96u3 trans-heterozygotes with fru null alleles, such as frusat15, survived to early pupal stages, dying at or just after pupal ecdysis, the same lethal phase of other known fru nulls (Table 1B; ANAND et al. 2001 Down). To address the possibility that some phenotypes of these fru escapers might be due to loss of function in the nearby spread gene (sprd, map location 91A5-6; SPRADLING et al. 1999 Down), we performed complementation testing with various fru alleles and deficiencies. Our results show that these fru mutations fully complement this sprd mutation, supporting the attribution of the lethality and visible mutant phenotypes to the loss of fru function (see MATERIALS AND METHODS; ANAND et al. 2001 Down).


 
View this table:
In this window
In a new window

 
Table 1. Mutant phenotypes of fruAJ96u3 homozygotes and heterozygotes with other fru alleles

Temporal and spatial distribution of fru mRNA during embryogenesis:
To determine the spatial and temporal distribution of embyonic fru transcripts, we performed in situ hybridizations with antisense-BTB and antisense-Com riboprobes, which detect most or all fru transcripts (RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; LEE et al. 2000 Down). We found that fru mRNAs are expressed in a dynamic temporal and spatial pattern from the beginning of embryogenesis until stage 16 (Fig 2; Table 2A). fru transcripts are uniformly distributed in very early embryos and become incorporated into segregating pole cells [stages (st) 1–5; Fig 2A]. At the start of gastrulation (st 6), heavily labeled cells are found in the ventral and cephalic furrows. In slightly older embryos (st 7–9; Fig 2B) the most prominent distribution of fru transcripts is found in the developing CNS within mesectodermal and ventral neuroectodermal cells. Transcripts become localized to delaminating neuroblasts (Fig 2B and Fig G) and after stage 10, fru transcripts are detected in medial but not in lateral neuroblasts (Fig 2H). Following expression in the progeny of neuroblasts, the level of fru expression in the CNS continues to decline until becoming undetectable at stage 16 (Table 2A; Fig 2I). Thus, fru transcripts are expressed throughout the development and early differentiation of the CNS but become undetectable at later stages. Cells in some non-CNS tissues, the amnioserosa and tracheal placodes, also expressed fru transcripts (st 9–11; Table 2A), but no in situ hybridization signal was detected in other tissues, such as the PNS or body wall muscles.



View larger version (132K):
In this window
In a new window
Download PPT slide
 
Figure 2. The temporal and spatial distribution of fru mRNA and Fru protein. In situ hybridization was carried out with digoxigenin-labeled antisense fruBTB riboprobes and AP histochemistry (A–C and G–I). Fru protein distribution was determined by immunohistochemical localization of anti-FruBTB' followed by AP histochemistry (D–F and J–L). In G–L, embryos were also labeled with anti-Engrailed antibody. (A) Stage 4 wild-type embryo. fru mRNA is found in pole cells (arrowhead). (B) Stage 8 wild-type embryo. Mesectodermal cells (arrow) are strongly labeled for fru mRNA. (C) Stage 11 fru null (fruw24/fruw24) embryo. No fru mRNA was detected in any cell types at this stage. (D) Stage 4 wild-type embryo. Fru protein is found in pole cells (arrowhead). (E) Stage 9 wild-type embryo. Cephalic regions (white asterisk) and two rows of mesectodermal cells (arrow; compare with B) express Fru protein. (F) Stage 14 fru null (fruw24/fruw24) embryo. No Fru protein was detected in any cell types at this stage. (G) Late stage 9 wild-type embryo. fru mRNA is found in three columns of neuroblasts: S1 neuroblasts (l, lateral column and m, medial column) and S2 neuroblasts (i, intermediate column). Engrailed-positive epidermal cells are present in a different focal plane. (H) Stage 10 wild-type embryo. fru mRNA appears to be in most GMCs (white arrow) and is also more strongly expressed in the anterior half of the segment. (I) Stage 11 wild-type embryo. fru mRNA is present but with less intensity than found in earlier stages. (J) Late stage 9 wild-type embryo. Fru protein is found in three columns of neuroblasts: SI neuroblasts (l, lateral column and m, medial column) and SII neuroblasts (i, intermediate column). (K) Stage 10 wild-type embryo. Fru protein is detected throughout the CNS, appears to be in most or all GMCs (white arrows), and is also more strongly expressed in the anterior half of the segment. (L) Stage 11 wild-type embryo. Fru protein is expressed in a large number of cells in the nervous system. There is slightly stronger expression in many medial neurons, anterior neurons, and cells along the midline. The size of cells (white arrows) and their relative positions indicate that they are likely to be neurons. A–F, whole-mount preparations; G–L, filleted embryo preparations. Vertical white bars (G–L) indicate the ventral midline. Anterior is to the left (A–F) or to the top (G–L). Bars, 20 µm (A and D; B, C, E, and F; and G–I are at the same magnification).


 
View this table:
In this window
In a new window

 
Table 2. The temporal and spatial distribution of fru mRNAs and Fru proteins in embryos

The fru locus encodes a complex set of transcripts (Fig 1; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down). To better understand the embryonic pattern of fru transcripts, we performed in situ hybridization with a set of 5' end riboprobes to distinguish transcripts made from different fru promoters (see MATERIALS AND METHODS; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down). We were unable to detect P1 or P2 transcripts at any embryonic stage using riboprobes specific to these transcripts (Table 2A). Thus, P1 transcripts, which encode the male-specific fru proteins, are not expressed in the embryo, a finding consistent with LEE et al. 2000 Down. Transcripts from P3 and P4 promoters were expressed during embryogenesis in a temporal and spatial pattern that mirrored that of fru transcripts detected by antisense-BTB or -Com riboprobes (Table 2A). In the developing CNS, both P3- and P4-specific riboprobes labeled mesectodermal and neuroectodermal cells followed by labeling of delaminating neuroblasts (Table 2A). At slightly later stages (st 9–11), medial neuroblasts continued to express P3 and P4 transcripts, but lateral neuroblasts no longer had detectable transcripts. In stages 7–12 embryos, the in situ hybridization signal for P4 transcripts was less intense, suggesting that the level of P4 transcripts was lower than that of P3 transcripts in these stages. However, P3 transcript levels became undetectable in all tissues after stage 12, whereas P4 transcripts were still detectable up to stage 16 (Table 2A). In summary, the in situ hybridization data show that both P3 and P4 fru transcripts are expressed in the developing CNS and, very likely, in the same cells. Furthermore, the higher level of fru transcripts detected with riboprobes to fru common sequences in stages 9–12 CNSs is likely due to the presence of both P3 and P4 transcripts whereas the lower level of fru transcripts in stages 12–16 CNSs reflects the presence of only P4 transcripts.

An additional complexity in fru transcripts reflects alternative splicing at the 3' end, which generates transcripts containing one of three different pairs of Zn-finger domains (Fig 1; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down). While it is known that P1 transcript isoforms are spliced to each of the three alternative 3' ends (GOODWIN et al. 2000 Down), the full complexity of the 3' alternative splicing of transcripts produced from the P2, P3, and P4 promoters is not known. We examined embryos by in situ hybridization with three different 3' end riboprobes to detect transcripts having the A, B, or C 3' ends (MATERIALS AND METHODS; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down). Overall, the temporal and spatial expression pattern of transcripts containing the A, B, and C 3' ends was consistent with the pattern found for fru transcripts labeled with antisense-BTB and antisense-Com riboprobes (Table 2A). In the developing CNS, transcripts containing the C 3' end appeared to be more abundant than those containing the A or B 3' ends (data not shown). In addition, some tissues, such as the tracheal placodes and amnioserosal cells, were labeled only when riboprobes to the C 3' end were used, suggesting that there is some tissue-specific regulation of the 3' alternative splicing of P3 and or P4 fru primary transcripts (Table 2A).

To confirm that we were detecting authentic fru transcripts, fru mutant embryos, fruw24/fruw24 and frusat15/frusat15, in which the coding regions of the fru gene are deleted, were labeled with the antisense-BTB, antisense-Com, and antisense-A 3' end riboprobes. At the beginning of embryogenesis, we detected transcripts in these null mutant embryos only up to stage 5; later stage embryos were not labeled (Fig 2C and Fig F). By contrast, fru transcripts in wild-type embryos are present up to stage 16 (Table 2A). From these results, we infer that fru transcripts in very early mutant and wild-type embryos are maternally derived, but that the transcripts found only in older wild-type embryos are zygotically generated. The presence of maternal and zygotic fru transcripts was consistent with the results of Fru protein immunohistochemistry (see below).

The temporal and spatial expression of Fru protein during embryogenesis:
To determine whether the fru transcripts present during embryogenesis are translated, embryos were labeled with antibodies directed against the common coding regions of Fru proteins (anti-FruCOM and anti-FruBTB') and against the class A 3' end (anti-FruA') and the class C 3' end (anti-FruC'; see MATERIALS AND METHODS). We found that the localization of Fru proteins during embryogenesis is largely consistent with the spatial and temporal RNA distribution described above (Table 2A). Before neuroblast delamination, mesectodermal cells (st 9), but not neuroectodermal cells, were labeled with both anti-FruCOM and anti-FruBTB' antibodies (Fig 2E; Table 2B). All delaminating neuroblasts and their progeny appear to express Fru proteins (st 9–10; Fig 2J). Ganglion mother cells (GMCs) located in the anterior regions of each segment label more strongly for Fru proteins than do those in the posterior regions (st 10; Fig 2K). At later stages (st 11–16), many cells in the CNS were strongly labeled (Fig 2L).

To determine whether Fru proteins were expressed in neurons and/or glia of stage 13–16 embryos, we carried out double- and triple-labeling experiments with anti-Elav antibodies to identify Fru-positive neurons and with anti-Repo antibodies to identify Fru-positive lateral glia (Fig 3A and Fig B). From a detailed comparison of double- (n = 5) and triple-labeled (n = 3) CNSs, it appeared that all Elav-positive cells in the CNS coexpress Fru proteins, even though there were variable levels of Fru protein expression in individual cells (Fig 3C). Likewise, all Repo-positive cells in the CNS were also Fru positive (n = 5, Fig 3C). In these experiments, some midline cells were only Fru positive (arrows, Fig 3C and Fig F). By their location, these cells are likely to be midline glia, which do not express Repo protein (HALTER et al. 1995 Down). In summary, all neurons and glia appear to express Fru proteins.



View larger version (108K):
In this window
In a new window
Download PPT slide
 
Figure 3. Coexpression of Fru protein with Elav, a neuronal marker, and Repo, a lateral glial marker, in the CNS and PNS. Filleted CNSs from wild-type embryos (st 16) were triple labeled with antibodies to Fru (red), Elav (green), and Repo (blue). A–C, D–F, and G–I are single confocal images in a dorsal CNS focal plane. The images that were merged in Adobe Photoshop are found in C, F, and I. J–L are composite merged images of the lateral body wall from embryos stained as above. (A) CNS cells labeled with anti-FruCOM antibody. The arrow points to a Fru-positive midline cell. (B) CNS cells labeled with anti-Elav and anti-Repo antibodies. (C) In this superimposed image of A and B, all neurons (yellow) and lateral glia (purple) colabel for Fru protein. The arrow points to the same Fru-positive midline cell as in A. (D) CNS cells labeled with anti-FruA' antibody. (E) CNS cells labeled with anti-Elav and anti-Repo antibodies. (F) In this superimposed image of D and E, most neurons (yellow) and glia (purple) colabel for FruA isoforms. The arrows point to Fru-positive midline cells shown in D. (G) CNS cells labeled with anti-FruC' antibody. (H) CNS cells labeled with anti-Elav and anti-Repo antibodies. Arrows point to two glial cells. (I) In this merged image of G and H, most neurons (yellow) but few glia (purple, arrows in H and I) colabel for FruC isoforms. (J) All peripheral sensory neurons (asterisk, yellow) are colabeled with anti-Elav and anti- FruBTB' but some glial cells are Fru positive (arrow, purple) and others are Fru negative (arrowhead, blue). The level of Fru expression is low in some sensory neurons and glial cells. (K) A few peripheral sensory neurons (arrowhead and asterisk, yellow) but many glial cells (arrow, purple) label for Fru isoforms that use the A 3' end. (L) Many peripheral sensory neurons (asterisk, yellow) but only a few glial cells (arrowhead, purple) label for Fru isoforms that use the C 3' end. Anterior is up for A–I and to the right for J–L. Bar, 20 µm.

We used antibodies specific to either the A or the C ZnF carboxy termini found in Fru isoforms to determine whether cells have Fru proteins with only one or both of these isoforms (see MATERIALS AND METHODS). The pattern of cells labeled with anti-FruA' is very similar to the spatial and temporal pattern of cells detected with anti-FruCOM and anti-FruBTB' (Table 2B). In contrast, in young embryos (st 1–11) the anti-FruC' labeling pattern is similar to the pattern of cells stained with anti-FruCOM and anti-FruBTB', whereas at later stages (st 12–16), fewer cells were labeled with anti-FruC' than with anti-FruCOM and anti-FruBTB'. By double- and triple-labeling experiments in stage 16 embryos, all Elav-positive neurons, Repo-positive lateral glia, and putative midline glial cells were FruA positive (n = 4, Fig 3, D–F). However, all neurons, but only some Repo-positive glia, were FruC' positive (n = 5, Fig 3, G–I). These results suggest that all neurons and some lateral glia contain Fru isoforms having at least two different carboxy termini, but that some lateral glia and midline cells contain Fru proteins that may have only one type of carboxy terminus. Currently, no antibody specific to the B carboxy terminus is available.

In contrast to the findings from the in situ hybridization experiments, Fru proteins were detected in neurons and glial cells in the PNS by anti-FruBTB', anti-FruCOM, anti-FruA', and anti- FruC' immunohistochemistry (Fig 3, J–L). In double- and triple-labeling experiments, some Fru-positive cells, labeled with anti-FruBTB' or anti-FruCOM antibodies, were Elav positive and by location were judged to be mechanosensory and chordotonal organ neurons as well as the more internal multidendritic neurons. Another population of Fru-positive cells were Repo-positive and thus were identified as peripheral glial cells (Fig 3J; Table 2B). However, double- and triple-labeling experiments using anti-FruA' and anti-FruC' antibodies showed that only a subset of the Fru-positive sensory neurons and peripheral glia had Fru proteins with the A and C carboxy termini, from which we infer that some of these cells have Fru proteins with the B carboxy terminus (Fig 3K and Fig L; Table 2B).

Fru proteins are also expressed in other embryonic tissues. The posterior epidermis (st 13–16) and most body wall muscles (st 14–16, Table 2B) were Fru positive by anti- FruBTB' and anti-FruCOM labeling. These tissues were labeled with anti-FruC' but not with anti-FruA' antibodies (Table 2B). These findings suggest that Fru protein isoforms with specific ZnF domains have a tissue-specific pattern in non-CNS tissues. The presence of Fru proteins in cell types that were not labeled in the in situ hybridization experiments, such as the PNS or muscle, may be due to differences in sensitivity of the molecular probes used and/or the relative levels of fru transcripts and proteins in these different cell types.

To be certain that authentic Fru proteins were being labeled in wild-type embryos, fru mutant embryos, fruw24/fruw24 and frusat15/frusat15, which are deleted for the fru gene, were labeled with anti-FruBTB', anti-FruCOM, anti-FruA', and anti-FruC' antibody (Table 2B). At early embryonic stages (st 1–5), the pattern of Fru protein expression in null mutant embryos was comparable to that in wild-type embryos. At later stages (st 6–16), no Fru proteins were detected in null mutant embryos (Fig 2F), even though there was still robust labeling in wild-type embryos. These results indicate that the earliest transcripts present, which we infer to be maternal in origin, are translated in very early stage embryos and that Fru proteins in stage 6–16 embryos are largely or exclusively derived from zygotic fru transcripts.

Neurons in the embryonic CNS and PNS are labeled in fru P-element lines:
To determine whether P elements inserted within or near the fru locus behave as enhancer traps of the embryonic pattern of fru expression, we examined ß-galactosidase activity in fru3, fru4, and frusat mutant and AJ96w+ embryos (Fig 1; CASTRILLON et al. 1993 Down; ITO et al. 1996 Down; SPANA and DOE 1996 Down). In fru3, fru4, and frusat mutations, a P element is inserted between the P2 and P3 promoters (Fig 1; CASTRILLON et al. 1993 Down; ITO et al. 1996 Down; RYNER et al. 1996 Down; GOODWIN et al. 2000 Down) and disrupts transcripts from the P1 and P2 fru promoters in pharate adult animals (GOODWIN et al. 2000 Down).

In fru P-element mutant and control sibling embryos, cells in the CNS and PNS were labeled by anti-ß-galactosidase. Similar temporal and spatial labeling patterns were observed in embryos from the fru3 and fru4 lines. In embryos from these lines, anti-ß-galactosidase expression was detected in the mesectoderm (st 8), delaminating neuroblasts (st 9; Fig 4A and Fig B), and a variety of smaller cells, which appear by their location to be GMCs (st 10), neurons (st 11), and lateral glia and midline cells (st 12; Fig 4C). ß-Galactosidase labeling persisted in these CNS cells until stage 16. In the embryonic PNS, sensory organ precursors (st 10) followed by the external and chordotonal sensory neurons (st 12–16) were ß-galactosidase positive (Fig 4C). In addition, tracheal cells (st 11) and epidermal cells in the posterior part of each hemisegment (st 13–16) were labeled (Fig 4C). By contrast, in embryos from the frusat line, no ß-galactosidase-positive cells were found in the embryonic CNS, and only the chordotonal neurons in the PNS were labeled (data not shown). In summary, these results indicate that ß-galactosidase expression from the P elements inserted in fru3 and fru4 lines largely replicates fru's pattern in the embryonic CNS and PNS.



View larger version (114K):
In this window
In a new window
Download PPT slide
 
Figure 4. ß-Galactosidase expression pattern in fru P-element mutant embryos. Whole-mount embryo (A) or filleted CNSs (B–D) from embryos labeled with anti-ß-galactosidase followed by AP histochemistry. (A) Whole-mount fru4 embryo (stage 9, ventral view). Cephalic (arrow) and ventral neuroblasts strongly express ß-galactosidase. (B) Filleted fru4 embryo (early stage 10, dorsal view). All ventral neuroblasts, including S1 neuroblasts (l, lateral column and m, medial column) and SII neuroblasts (i, intermediate column), are uniformly labeled. (C) Filleted fru4 embryo (stage 13, composite of dorsal to ventral views to show ventral nerve cord and lateral tissues). At later stages, the expression pattern in the ventral nerve cord shifts to a small number of midline cells (large arrows) and lateral cells, which are likely to be both glia (small arrows) and neurons based on the focal plane. Sensory neurons (white arrowheads), peripheral glia (small black arrowhead), and epidermis (white brackets) also strongly express ß-galactosidase. (D) Filleted AJ96w+embryo (stage 13). Two midline neurons, dMP2 and vMP2, are strongly labeled (arrows; SPANA and DOE 1996 Down) as are sensory neurons (arrowhead). Vertical black bar (C and D) indicates the ventral midline of embryo. Anterior is up. Bars, 20 µm (C and D, same magnification).

We also examined the expression pattern of the enhancer trap line AJ96w+. Previous studies have shown that the MP2 neuroblast and its progeny, the dorsal and ventral midline precursor neurons (dMP2 and vMP2), express ß-galactosidase in the AJ96w+ line (SPANA and DOE 1996 Down). The ventral CNS also showed very weak generalized neuronal expression from stage 14 to 16 and expression in a few lateral sensory neurons (Fig 4D). The generalized ventral nerve cord and sensory neuron labeling in embryos of the AJ96w+ line is similar to the pattern of expression in the fru3and fru4 lines, but these two fru lines did not show prominent MP2 or dMP2/vMP2 neuronal staining.

fru function is required for the formation of axonal tracts within the CNS:
Given the findings that the fru gene is widely expressed in the embryonic CNS, we expected that fru mutant embryos would have defects in CNS development and used two antibodies, anti-FasII and mAb BP102, to assay axonal projections within the CNS. FasII is a neural adhesion molecule expressed on the cell surface of axons forming specific longitudinal fascicles or tracts running throughout the entire ventral nerve cord and into the brain (Fig 5A; GRENNINGLOH et al. 1991 Down; GOODMAN and DOE 1993 Down; LIN et al. 1994 Down; HIDALGO and BRAND 1997 Down). In whole-mount or flat-dissected preparations of stage 16 and 17 wild-type embryos, three tracts, medial, intermediate, and lateral, are visible in the CNS.



View larger version (145K):
In this window
In a new window
Download PPT slide
 
Figure 5. Axonal defects in the CNS of fru mutant embryos. Filleted CNSs from wild-type and fru mutant embryos (late stage 16) were stained for anti-FasII (A–C) and BP102 (D–F) using HRP histochemistry. (A) In a wild-type embryo, three bilaterally symmetric FasII longitudinal fascicles are visible. (B) In a fruw12/frusat15 embryo, all fascicles within a segment are disrupted. Brackets indicate the area shown at higher magnification in C. (C) Axons in all three fascicles have defasciculated. Axons in the medial MP1 fascicle extend toward the midline (arrowhead and arrow). (D) In a wild-type embryo, BP102-positive axonal processes in each segment form a bilaterally symmetric pair of longitudinal connectives along with the anterior and posterior commissures. (E) In a fruw12/frusat15 embryo, neither the longitudinal connectives (arrow) nor the commissures are uniform in size, suggesting that unequal numbers of axons are present. In some segments (arrow), the commissures are missing. (F) A higher power view of bracketed region in E to show the lack of axonal processes crossing the midline (arrowhead). Bars, 20 µm (A, B, D, and E, same magnification; C and F, same magnification).

FasII-positive tracts are abnormal in fru mutants lacking all or most fru transcripts. Between 12 and 25% of fru null mutant embryos (e.g., frusat15/fruAJ96u3) had abnormal FasII-positive tracts (Fig 5B and Fig C; Table 3D). By comparison, <3% of wild-type embryos had any segments with disrupted FasII tracts (Table 3A). In all fru null mutant CNSs, FasII-positive axons no longer formed distinct tracts in one or more adjacent hemisegment, suggesting that these axons had defasciculated from other axons within the tracts. In some cases, axons that had defasciculated crossed and joined an adjacent fascicle or approached and crossed the midline (Fig 5C). In other cases, the left and right medial tracts appeared to merge along the midline.


 
View this table:
In this window
In a new window

 
Table 3. Analysis of abnormal axonal projections in the CNS of fru mutant embryos

To determine whether many or most axonal tracts were disrupted in fru mutants, we labeled the longitudinal connectives and commissures with the BP102 antibody (Fig 5D; SEEGER et al. 1993 Down). Almost 20% of the fru null mutant embryos had defects in the pattern and distribution of BP102-positive axons in the connectives and commissures compared to only 1% of wild-type embryos (Table 3A and Table 3D). Most commonly, in these mutants, the commissures and connectives were not uniform but were either thicker, as though more axons were present, or thinner, as though fewer axons were present (Fig 5E and Fig F; Table 3C and Table 3D).

To demonstrate that these FasII and BP102 axonal defects depended on the loss of fru function, we used the fruw12 allele, which has a chromosomal break within the fru locus, in combination with fru deletion mutations (Fig 1; Table 3C). We found that 15–23% of these mutant embryos had defects in their FasII and BP102 tracts; the frequency and the severity of the defects were similar to those found in fru null embryos (Fig 5B and Fig C). The fruw12 allele is caused by a chromosomal inversion, and to rule out the possibility that the non-fru inversion breakpoint contributes to the FasII mutant phenotype, we examined fruw12/Df(3L)XD198 mutants and found that the pattern of FasII fascicles was wild type (n = 10; data not shown; see MATERIALS AND METHODS). These results show that it is the loss of fru function that causes the axonal defects in FasII and BP102 tracts (Table 3C and Table 3D). The chromosomal break in the fruw12 allele in the fru locus separates the P1, P2, and P3 promoters from the fru coding region but leaves the P4 fru transcription unit intact (ANAND et al. 2001 Down). This result suggests that fru transcripts from the P1, P2, or P3 promoters are important for wild-type axonal pathfinding.

To further define which fru transcripts are required for the formation of FasII and BP102 tracts, we examined fru mutants in which P1 transcripts are affected or where P1 and P2 transcripts are eliminated (e.g., fru4-40/frusat15; Table 3B; ANAND et al. 2001 Down). These mutants had wild-type FasII and BP102 axonal tracts and produced P3 and P4 transcripts (Table 3B). The finding that P1 and P2 fru transcripts are not required for the formation of FasII and BP102 tracts is consistent with evidence by in situ hybridization that these transcripts are not present in embryos (Table 2A). By considering the different fru mutant genotypes examined, we infer that expression of P3 and, perhaps, P4 fru transcripts is sufficient for the development of wild-type FasII and BP102 tracts. The role of P4 transcripts in this process is inferred from data of mutants expressing the fruw12 allele and it is possible that P4 transcripts, while present, are not expressed as in wild-type animals (ANAND et al. 2001 Down).

fru function is required for wild-type orientation of pioneering axonal projections:
If the axonal pathfinding defects in fru mutants are due to the loss of fru function in neuronal precursors or in neurons themselves, then there are two likely explanations for the altered axonal trajectories in these mutants. One explanation is that neurons have not adopted, or only partially adopted, their wild-type identity in fru mutants and thus their axons fasciculate with different axonal partners as they grow in the CNS. An alternative explanation is that neurons in fru mutants adopt their wild-type identity but are unable to carry out their normal program of axonal pathfinding and differentiation. To distinguish between these two possibilities, we used neuronal and axonal markers to identify the earliest developmental abnormalities in fru mutants.

To assess whether fru played a role in neuroblast delamination and identity, we first labeled developing neuroblasts with antibodies to the Hunchback (Hb) protein, which labels all delaminating neuroblasts by early stage 9 in wild-type embryos (Fig 6A, n = 10). Fewer neuroblasts were labeled with anti-Hb antibody in early stage 9 fruw12/frusat15 embryos than in wild type, but neuroblasts in all three rows did become Hb positive in late stage 9 embryos (Fig 6B and Fig C; n = 10 both stages). Thus, the final pattern of Hb expression was wild type in these fru mutant embryos but there was a slight temporal delay in either neuroblast delamination itself or the onset of Hb expression in delaminating neuroblasts.



View larger version (178K):
In this window
In a new window
Download PPT slide
 
Figure 6. Neuroblast and neuronal identity and early axonal projections in the CNS of fru mutant embryos. Filleted CNSs from wild-type and fru mutant embryos labeled with anti-Hunchback (A–C), mab22C10 (D, E, G, and H), anti-Oddskipped (F), and anti-FasII (I–L) antibodies using AP (A–H) or HRP histochemistry (I and J). (A) Early stage 9 wild-type CNS. Full complement of Hb-positive NBs in medial (m), intermediate (i), and lateral (l) columns. Rows of En-positive cells (arrowheads) indicate the position of posterior compartments in A–C. (B) Early stage 9 fruw12/fruw24 CNS. Fewer Hb-positive neuroblasts (arrow) are found at this stage than in wild-type embryos. (C) Late stage 9 fruw12/fruw24 CNS. Hb-positive neuroblasts in all columns are present in a pattern similar to that in wild-type embryos. (D) Midstage 12 wild-type CNS. The mab22C10-positive vMP2 neuron (white arrow) projects its axon anteriorly (white arrowhead) and the dMP2 neuron (arrow) initially projects its axon posteriorly (arrowhead). (E) Midstage 12 fruw12/frusat15 CNS. vMP2 and dMP2 neurons often do not express mab22C10 as strongly as does wild type. In some segments, mab22C10-positive neurons were not in their typical anterior-posterior location (indicated by asterisk) and had delayed outgrowth of axonal processes (white arrowhead). The white arrow points to a cell with an abnormally oriented growth cone. (F) Midstage 12 fruw12/frusat15 CNS. Odd-skipped-positive vMP2 (white arrowhead) and dMP2 (white arrow) neurons are present in the fru mutant embryo. (G) Early stage 13 wild-type CNS. Initial axonal outgrowth forming the mab22C10 medial fascicle (white arrow). (H) Early stage 13 fruw12/frusat15 CNS. The medial fascicle (asterisks) is not yet formed. (I) Midstage 12 wild-type CNS. FasII-positive aCC neuron (white arrow) extends its axon peripherally (white arrowhead) and the FasII-positive pCC neuron (arrow) projects its axon anteriorly (arrowhead). (J) Midstage 12 fruw12/P14 CNS. In the more anterior hemisegment, the FasII-positive aCC neuron (white arrow) extends its axonal growth cones toward the periphery (white arrowhead) and the pCC neuron (arrow) sends its axon anteriorly (arrowhead). In the other hemisegment both aCC and pCC axons extend anteriorly (asterisk). (K) Early stage 13 wild-type CNS. The developing FasII medial fascicle (arrow) is well organized. All aCC neurons have extended their axons posteriorly (white arrowheads). (L) Early stage 13 fruw12/P14 CNS. The developing FasII medial fascicle (arrow) is indistinct, suggesting that the axons are not as fasciculated as those in wild type. In one hemisegment, the FasII-positive aCC axon (white arrow) extends posteriorly, not toward the periphery. Other aCC axons (white arrowhead) extended to the periphery. Anterior is to the top. The midline is to the right (I–L). Bars, 20 µm (A–C, same magnification; D–L, same magnification).

We next examined the development of neurons in fru mutants that pioneer the FasII fascicles to better assess whether there were changes in neuronal identity or early defects in axonal differentiation. In the wild-type CNS, pCC, vMP2, dMP2, and MP1 axons initiate the formation of the medial and intermediate FasII tracts within each segment (HIDALGO and BRAND 1997 Down; HIDALGO and BOOTH 2000 Down). The axonal process of the pioneer neurons vMP2 and pCC ascends while the processes of the MP1 and dMP2 axons fasciculate and extend posteriorly. These axons initially produce one fascicle at stage 13, which then splits into two fascicles, the pCC/vMP2 (medial) and dMP2/MP1 (intermediate) fascicles.

We therefore examined the development of aCC, pCC, vMP2, and dMP2 neurons in frusat15/fruAJ96u3 and fruw12/fruAJ96u3 embryos. Along the midline, the MP2 precursor expresses the Odd-skipped protein and upon division the dMP2 daughter cell maintains Odd-skipped expression while the vMP2 daughter downregulates Odd-skipped expression (BROADUS et al. 1995 Down; SPANA and DOE 1996 Down). In fru mutant embryos all segments had the expected complement of Odd-skipped neurons along the midline (Fig 6F; fruw12/fruAJ96u3 and frusat15/fruAJ96u3, n = 35 segments, n = 5 embryos of each genotype). The other pioneer neurons, aCC and pCC neurons, can be recognized by their location and FasII expression in stage 12 embryos (Fig 6I; GRENNINGLOH et al. 1991 Down). In fru mutant embryos, aCC and pCC neurons were present and beginning to extend their axonal processes (Fig 6J). These results show that in fru mutant embryos, neurons pioneering the medial and intermediate FasII tracts express markers appropriate for their expected neuronal fate.

To assess the early outgrowth of axons from these neurons as they begin to differentiate their axons, we labeled neurons with markers to assess axonal outgrowth. The mab22C10 antibody recognizes the futsch protein, which labels the vMP2 and dMP2 axons and is needed for the normal outgrowth of axonal processes (Fig 6D; HUMMEL et al. 2000 Down). In fru mutant embryos (st 12), the somas and axons of vMP2 and dMP2 neurons were strongly labeled in only 20–33% of the hemisegments (Fig 6E; 10/50 hemisegments, n = 16 fruw12/fruAJ96u3 embryos; 28/84 hemisegments, n = 20 frusat15/fruAJ96u3 embryos). Every fru mutant embryo examined had hemisegments in which neither the dMP2 or vMP2 cell body nor their axonal processes were labeled (Fig 6E) whereas 92% of the wild-type embryos had heavily labeled neurons (Fig 6D; n = 100 hemisegments, 13 embryos). In those mab22C10-positive dMP2 and vMP2 neurons in which the initial outgrowth of axonal growth cones could be determined, axonal outgrowth was delayed or, if present, the growth cone appeared to be initiating growth in an abnormal direction (Fig 6E). At slightly later stages (st 13), many of these mab22C10-positive dMP2 and vMP2 axons had not yet formed the medial fascicle or if the fascicle was present its organization was abnormal (Fig 6H) compared to the developing medial fascicle in wild-type embryos (Fig 6G). FasII-positive axons also contribute to the medial fascicle and in fru mutants these axons do not form distinct fascicles as found in wild type (compare Fig 6K TO 6L). Early axonal outgrowth of the FasII aCC motorneurons occasionally fails to initially grow toward the periphery, either joining the ascending pCC axon (Fig 6J) or growing posteriorly (Fig 6L). These findings show that the initial emergence of the growth cones from these pioneer neurons is delayed or abnormal in fru mutants.

fru function is not required for lateral and midline glial cell survival:
The axonal phenotypes in fru mutant embryos might also result from the loss of midline or lateral glial cells, both of which have been shown to be necessary for the formation of normal axonal tracts and to express Fru proteins (Fig 3C, Fig F, and Fig I; HALTER et al. 1995 Down; GIESEN et al. 1997 Down; SCHOLZ et al. 1997 Down; HUMMEL et al. 1999 Down). We examined fru mutant embryos to determine if both types of glia were present in the appropriate numbers and locations within the CNS. In fruw12/frusat15 embryos, the average number of Repo-positive glial cells (Fig 7B; 44 ± 4 glia/neuromere, n = 4) was not different from that in wild-type embryos (Fig 7A; 45 ± 4 glia/neuromere, n = 4; P > 0.05, two-sample t-test). The pattern of Repo-positive glial cells was slightly abnormal in fru mutants (Fig 7B). To label midline glial cells, the AA142 enhancer trap P element was recombined onto the frusat15 and fruAJ96u3 chromosomes (SCHOLZ et al. 1997 Down). fru mutant embryos had a wild-type pattern of three to four midline glial cells expressing ß-galactosidase (n = 5, fruw12/fruAJ96u3; n = 6, frusat15/fruAJ96u3 embryos). Since wild-type numbers of glial cells are present in fru mutants, it does not appear that fru is required for the survival of glial cells. Thus the defects in the FasII and BP102 axonal tracts do not appear to be due to a loss of midline or lateral glia.



View larger version (75K):
In this window
In a new window
Download PPT slide
 
Figure 7. Repo-positive glial cells are present in the fru mutant CNS. Filleted CNSs from wild-type and fru mutant embryos were labeled with anti-Repo antibody and visualized with nickel-enhanced HRP histochemistry. (A) Stage 14 wild-type CNS. A regular array of longitudinal glia are present. (B) Stage 14 fruw12/frusat15 CNS. The number of longitudinal glia present is similar to that found in wild-type CNS but the glial cells are more distributed in the mutant. Anterior is to the top. Bar, 20 µm.

The expression of specific UAS-fru transgenes rescues mutant defects in the CNS of fru mutant embryos:
The phenotypic analysis of fru mutant embryos along with fru's temporal and spatial expression pattern suggests that the fru gene functions during axonal outgrowth. To positively demonstrate fru's role in the CNS, we rescued fru mutant defects by the expression of UAS-fru transgenes controlled by a pan-neuronal driver, scabrous (sca)-GAL4 (BRAND and PERRIMON 1993 Down). The expression pattern of the sca-GAL4 driver line used was confirmed with a UAS-lacZ reporter transgene; uniform ß-galactosidase expression was found first in the neuroectoderm, followed by expression in neuroblasts, GMCs, and neurons through stage 16 (KLAES et al. 1994 Down; data not shown). This pattern mirrors Fru's expression pattern in the CNS (see above). We generated three different fru constructs that encode the same BTB and Common sequences but differ in which one of the three 3' ZnF domain sequences was included; these constructs are designated as UAS-fruA, UAS-fruB, and UAS-fruC (see MATERIALS AND METHODS).

The expression of UAS-fruA and UAS-fruC transgenes under the control of a sca-GAL4 driver was sufficient to rescue the defects in FasII and BP102 axonal tracts in fru mutant embryos (Fig 8A, Fig C, Fig D, and Fig F; Table 4). Embryos from two lines with independent UAS-fruA and UAS-fruC insertions in the fruw12/frusat15 mutant background were examined (Fig 8A and Fig C; Table 4). In both lines of sca-GAL4/UAS-fruA; fruw12/frusat15 embryos, the wild-type BP102 pattern was also restored (Fig 8D; Table 4). However, the BP102 pattern was rescued in embryos from only one of the UAS-fruC; sca-GAL4; fruw12/frusat15 lines (Fig 8F); in the other line, 33% of fru mutant embryos had an abnormal BP102 pattern (Table 4).



View larger version (151K):
In this window
In a new window
Download PPT slide
 
Figure 8. The expression of specific fru transgenes rescues the axonal defects in FasII- and BP102-positive axons in fru mutants, but the expression of male-specific fru transgenes disrupts axonal tracts in the CNS. Filleted CNS from fruw12/frusat15 embryos (st 16) expressing a UAS-fru or UAS-fruM transgene under the control of the sca-GAL4 driver was labeled for anti-FasII (A–C and G–I) or BP102 (D–F) followed by HRP histochemistry. (A) CNS of fru embryo expressing the UAS-fruA transgene. All segments have a normal pattern of FasII tracts. (B) CNS of fru embryo expressing the UAS-fruB transgene. All segments have a more abnormal pattern of FasII tracts (bracket) than does the fruw12/frusat15 mutant embryo alone (see Fig 5B). In addition, many axons project across the midline (arrow). (C) CNS of fru embryo expressing the UAS-fruC transgene. All segments have a normal pattern of FasII tracts. (D) CNS of fru mutant embryo expressing the UAS-fruA transgene. All segments have a normal pattern of BP102-positive longitudinal connectives and commissures. (E) CNS of fru embryo expressing the UAS-fruB transgene. Many segments have a pattern of BP102-positive longitudinal connectives and commissures slightly more abnormal than that of wild type. (F) CNS of fru mutant embryo expressing the UAS-fruC transgene. All segments have a normal pattern of BP102-positive longitudinal connectives and commissures. (G) CNS of fru embryo expressing the UAS-fruMA transgene. All segments have defasciculated (bracket) and midline crossing (arrow) FasII-positive axons. (H) CNS of fru embryo expressing the UAS-fruMB transgene. All segments have defasciculated (bracket) and midline crossing (arrow) FasII-positive axons. (I) CNS of fru embryo expressing the UAS-fruMC transgene. All segments have defasciculated (bracket) and midline crossing (arrow) FasII-positive axons. Anterior is up. Bar, 20 µm.


 
View this table:
In this window
In a new window

 
Table 4. Pattern of FasII and BP102 axonal tracts in fru mutants expressing UAS-fru transgenes in the CNS: the fru transgene expression by scabrous-GAL4

In contrast to the results obtained from expressing the UAS-fruA and UAS-fruC transgenes, the FasII and BP102 mutant phenotypes were more severe in the CNSs of sca-GAL4/UAS-fruB; fruw12/frusat15 embryos than in the CNSs of the corresponding fru mutants (Table 3C and Table 4). The FasII labeling in the CNS of these embryos was diffuse, indicative of highly defasciculated axonal projections, and axons frequently crossed between fascicles or across the midline (Fig 8B; Table 4). Not surprisingly, the BP102 pattern in both lines of sca-GAL4/UAS-fruB; fruw12/frusat15 embryos was also severely disrupted (Fig 8E; Table 4). Sibling embryos, sca-GAL4/UAS-fruB; fru-/fru+, also had had defective FasII and BP102 axonal tracts (95% embryos, n = 20, figure not shown). Taken together, these results indicate that the sca-GAL4-driven expression of UAS-fruB may be exerting a dominant negative effect on the development of these FasII and BP102 axonal phenotypes. In addition, the defects in mab22C10-positive axons in the dMP2 and vMP2 pioneer neurons in UAS-fruA, UAS-fruB, or UAS-fruC fruw12/frusat15 mutants were not rescued (n = 50 hemisegments of fru mutant embryos expressing each construct; data not shown).

To determine whether Fru function in postmitotic neurons might be sufficient to restore wild-type FasII tracts in fru mutants, we used an elav-GAL4 driver to express the UAS-fru transgenes (LIN and GOODMAN 1994 Down). In every case, the mutant phenotypes were not rescued; rather, more embryos developed defective FasII tracts and individual embryos had more affected hemisegments than were found in the fru mutant genotype alone (Table 5). These findings suggest that fru transgene expression solely in neurons is insufficient to restore normal FasII axonal phenotype in fru mutant embryos and interferes with the development of normal pathfinding by FasII axons.


 
View this table:
In this window
In a new window

 
Table 5. Pattern of FasII and BP102 axonal tracts in fru mutants expressing UAS-fru transgenes in the CNS: the fru transgene expression by elav-GAL4

The male-specific transcripts of fru derived from the P1 promoter encode an additional N-terminal extension to the common coding sequences of most fru transcripts but are not expressed in the embryo (Table 2A; ITO et al. 1996 Down; RYNER et al. 1996 Down; USUI-AOKI et al. 2000 Down). To ask if these P1 fru transcripts might also be able to rescue the defective axonal projections in fru mutants, we used three fru constructs derived from male-specific fru cDNAs (see MATERIALS AND METHODS). These constructs, designated as fruMA, fruMB, and fruMC, were made from the sequences encoding the 101 male-specific amino termini and the BTB and Common coding sequences and had sequences for one of the three different 3' ends. The FasII- and BP102-positive axonal tracts were defective in virtually all UAS-fruMA/sca-GAL4; fruw12/frusat15, UAS-fruMB/sca-GAL4; fruw12/frusat15, and UAS-fruMC /sca-GAL4;fruw12/frusat15 embryos (Fig 8, G–I; Table 4). In these embryos, FasII axons were defasciculated and often crossed the midline (Table 4). Thus, the male-specific UAS-fruM transgenes interfered globally with axonal patterning, suggesting that these fru male-specific proteins are unable to function in the same way as the Fru proteins encoded by other fru promoters.


*  DISCUSSION
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

fru transcripts and proteins are expressed during embryogenesis:
This is the first report showing that fru transcripts and proteins are expressed during embryogenesis (but see ZOLLMAN et al. 1994 Down; LEE et al. 2000 Down). Fru proteins are present in neuronal precursors, neuroblasts (NBs), GMCs, and their progeny, neurons and glia. Furthermore, using promoter-specific riboprobes for in situ hybridization, we have shown that the fru transcripts in the embryo are generated from the P3 and P4 promoters, but not from the P1 or P2 promoters. The presence of fru transcripts at very early embryonic stages suggests that at least some fru transcripts are likely to be produced maternally and then sequestered in the oocyte (M. FOSS and B. J. TAYLOR, personal communication).

The presence of multiple isoforms and tissue-specific patterns of expression are common characteristics of the BTB/POZ-ZnF transcription factor family. For example, the tramtrack (ttk) gene encodes two isoforms, Ttkp69 and Ttkp88, that are expressed in the CNS and PNS. The Ttkp69 protein is expressed in CNS glial cells and Ttkp88 is expressed in the peripheral nervous system (GIESEN et al. 1997 Down); Ttkp69 has been implicated in the formation of wild-type axonal tracts in the CNS (GIESEN et al. 1997 Down). Another gene with a similar structure to fru is the Broad-Complex (BR-C) in which a family of BTB/POZ-ZnF transcription factors is encoded by a single primary transcript that is spliced into four transcripts sharing a common 5' end spliced alternatively to 3' sequences encoding one of four pairs of C2H2 zinc-finger domains (Z1, Z2, Z3, and Z4; BAYER et al. 1997 Down). Phenotypic analysis of BR-C mutants, in which the expression of individual isoforms is disrupted, has led to the proposal that certain isoforms have specific functions. For example, the Z1 isoform mediates the reduced bristle on palpus wild-type function and the Z2 isoform mediates the broad wild-type function (DIBELLO et al. 1991 Down; SANDSTROM et al. 1997 Down). Although all tissues during metamorphosis appear to contain all BR-C isoforms, the relative abundance of the different isoforms is tissue specific and is thought to contribute to tissue specificity in the response to ecdysone (RESTIFO and MERRILL 1994 Down; BAYER et al. 1997 Down; RESTIFO and HAUGLUM 1998 Down).

Compared to these BTB/POZ-ZnF genes, the fru gene has additional complexity, including multiple promoters as well as alternative 5' and 3' end splicing. This transcript complexity means that tissue- and stage-specific gene expression may be regulated by the choice of the promoter as well as alternative splicing. In the best-understood example of fru transcript regulation, P1 fru transcripts are expressed in the CNS from late larval through adult stages and show sex-specific splicing at the 5' end of the primary transcript and sex-nonspecific alternative splicing of the 3' ends (GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down; S. F. GOODWIN, L. C. RYNER, T. CARLO, M. FOSS, J. C. HALL, B. J. TAYLOR and B. S. BAKER, unpublished results). The outcome of this sex-specific splicing regulation is the translation of P1 transcripts in males but not in females (LEE et al. 2000 Down; USUI-AOKI et al. 2000 Down).

For the other fru transcripts derived from the P2, P3, and P4 promoters, little is known of their regulation. Our results suggest that in the CNS most or all neurons and glia express transcripts derived from both the P3 and P4 promoters. The finding that transcripts having any one of the three different 3' ZnF domains are also widely expressed suggests that neurons and glia likely coexpress multiple Fru isoforms with different ZnF domains. If both P3 and P4 transcripts are spliced to use the full range of alternative 3' ends, there may be as many as six different fru transcripts within individual neurons or glia. These alternative 3' ends encode peptides that differ in size as well as in the position and sequence of the ZnF domain (GOODWIN et al. 2000 Down; USUI-AOKI et al. 2000 Down). Thus, most or all CNS neurons and glia appear to have multiple Fru isoforms but it is not known whether these proteins will have different functions. In only a few embryonic cell types, such as skeletal muscle, peripheral neurons, and glia, was there evidence from immunohistochemical analysis for isoform-specific expression of Fru proteins.

Our finding of a good correspondence between the cell types that were ß-galactosidase positive in the fru3 and fru4 P-element lines and the pattern of Fru antibody labeling suggests that enhancers sufficient to control fru's embryonic expression pattern are located in nearby regions. The similarity in the pattern of label in the fru3 and fru4 lines indicates that these embryonic enhancers are likely to be distributed in the 40-kb region between the relevant P-element insertion sites located between the P2 and P3 promoters (GOODWIN et al. 2000 Down). By comparison, the number and pattern of labeled cells in the frusat and fru4 lines are not identical, even though their P elements are inserted in essentially the same genomic location, suggesting that either intrinsic features of these P elements or their orientation affects reporter gene expression (GOODWIN et al. 2000 Down).

The formation of longitudinal and commissural tracts in the embryonic CNS depends on fru function:
Our results show that the fru gene has sex-nonspecific functions in the development of the embryonic axonal scaffold. fru mutants that lack most or all fru transcript classes formed longitudinal and commissural axonal tracts in which axons did not coalesce into fascicles, fasciculated with inappropriate partners, or were unable to maintain proper fasciculation. Consistent with the in situ hybridization experiments, fru mutants, in which P1 or P1 and P2 transcripts were disrupted, formed wild-type FasII and BP102 tracts. By contrast, in fru mutants where P1, P2, and P3 transcripts were disrupted, but P4 transcripts were present, the defects in FasII and BP102 axonal tracts were as severe as the defects in embryos completely lacking fru function. Consideration of the axonal phenotypes in these different fru mutant genotypes suggests that P3 fru transcripts are sufficient for the formation of wild-type FasII and BP102 tracts. Even though this explanation is the simplest that accounts for our data, we are unable to assess the effects of the loss of transcripts from only the P2, P3, or P4 promoter. Thus, we are unable to rule out the possibility that elimination of other fru transcripts or combinations of transcripts might also result in defective axonal pathfinding.

The embryonic phenotypes of complete loss of fru mutants are mild with only a fraction of mutant embryos showing defects in their axonal tracts. This relatively benign phenotype suggests that the activity of other genes may be able to compensate for the loss of fru function. Mutants in other genes, such as fasII, Dlar, and other receptor protein tyrosine phosphatases that encode fasciculation and guidance molecules, also exhibit weak phenotypes in single mutants but show much stronger phenotypes in double mutants or when heterozgyous with mutations that reduce the function of genes that operate in the same developmental pathway (GRENNINGLOH et al. 1991 Down; SEEGER et al. 1993 Down; KRUEGER et al. 1996 Down; SUN et al. 2000 Down).

fru expression in the embryonic CNS rescues axonal pathfinding defects in fru mutants:
The widespread expression of the fru gene in neurons and lateral and midline glia suggests that its function may be required in each of these three cell types and that it influences a variety of cellular processes necessary for the formation of a wild-type axonal scaffold. Each of these three cell types has been shown to function during the creation of the wild-type axonal scaffold (KLAMBT 1993 Down; GINIGER et al. 1994 Down; HUMMEL et al. 1999 Down; TEAR 1999 Down; HIDALGO and BOOTH 2000 Down). We found that the expression of fru transgenes in neuronal precursors and neurons, producing proteins similar to those encoded by P3 and P4 fru transcripts, rescued axonal pathfinding defects in fru mutants. Expression of the UAS-fruA and UAS -fruC transgenes controlled by the sca-GAL4 driver provided the most effective rescue of the fru mutant FasII and BP102 axonal phenotypes, suggesting that these transgenes encode Fru isoforms with very similar functions.

By contrast, the UAS-fruB transgene did not rescue the mutant axonal phenotypes when expressed with the same pan-neuronal sca-GAL4 driver, but instead led to an increase in the severity and frequency of abnormal FasII and BP102 tracts. The simplest explanation for these results is that the FruB isoform, unlike the FruA and FruC isoforms, is not able to functionally replace other Fru isoforms. The increased severity of the phenotypes in these embryos suggests that the FruB isoform may interfere, perhaps as a dominant negative factor, with the function of the FruA and/or FruC isoforms or with other proteins involved in axonal pathfinding. Alternately, sca-GAL4-driven FruB expression may not replicate the wild-type temporal or spatial pattern or expression level of FruB proteins and these differences in expression may be responsible for the exacerbated axonal phenotypes. Furthermore, our results also show that the misexpression of all of the male-specific Fru isoforms leads to an increased severity in the FasII and BP102 mutant phenotypes of fru mutant and control sibling embryos. Since embryos do not normally produce these FruM proteins, the ectopic expression of these FruM proteins appears to interfere with the function of one or more of the other Fru isoforms or with the activity of proteins needed for wild-type axonal pathfinding.

In contrast, the expression of fru transgenes in postmitotic neurons by the elav-GAL4 driver failed to rescue fru mutant axonal phenotypes. This failure to rescue suggests that the fru gene may function at earlier stages in neuronal development, such as in neuroblasts or in GMCs, in order for the axons to make the right axonal pathfinding decisions or that fru function in other cell types, such as glial cells, is also required for wild-type axonal pathfinding. This explanation is supported by the finding of genetic interactions between fru and other genes involved in generating or responding to repulsive signaling of axons crossing the midline (H.-J. SONG and B. J. TAYLOR, unpublished observations). Somewhat surprising was the finding that fru mutant embryos developed a more severe axonal defasciculation when fru transgenes were expressed only in neurons. The exacerbation of the fru mutant phenotype may indicate that the level of fru transcripts in neurons is important and that levels of Fru proteins different from those found in wild-type neurons might result in disruptions of normal axonal pathfinding or the interaction of these neurons with fru- glial cells.

fru's role in the embryonic CNS appears to be largely in the regulation of axonal outgrowth, not in the initial acquisition of neuronal identity:
The FasII and BP102 axonal pathfinding defects we found in fru mutant CNSs might result from the failure of neurons to adopt their proper cell fate or their ability to differentiate according to their fate. Since P3 and P4 fru transcripts are strongly expressed during NB delamination and early neurogenesis, the time at which neuronal fate decisions are being made, it was possible that fru's main function would be in fate determination. We found that four neurons, dMP2, vMP2, aCC, and pCC, responsible for pioneering the medial and intermediate FasII tracts expressed the appropriate identity markers, Odd-skipped and FasII (GRENNINGLOH et al. 1991 Down; SPANA and DOE 1996 Down; HIDALGO and BRAND 1997 Down; HIDALGO and BOOTH 2000 Down). These results suggest that in fru mutants these neurons have adopted, at least partially, their initial wild-type fate. In support of this finding, we found that in fru mutants lacking all or most fru transcripts, all aCC and pCC neurons express Even-skipped. The loss of fru function, however, does affect the ability of some of these neurons to maintain Even-skipped expression at later embryonic stages (H.-J. SONG and B. J. TAYLOR, unpublished observations). We have not examined all possible markers for these neurons and it may be that some cell fate markers are not expressed appropriately in fru mutants. The delay in the onset of Hb expression in neuroblasts may also indicate that fru has a small early role in neurogenesis. In addition, we examined neuronal identity in a very small population of neurons that have a very specific pioneering function; it may very well be that the fru gene plays a role in establishing neuronal identity in other embryonic neurons.

In fru mutants, the earliest defects we observed in FasII pioneering neurons were in the orientation and outgrowth of their initial axonal projections. In some neurons, axonogenesis appeared to be delayed, whereas in other neurons the initial axonal process was oriented abnormally and/or did not appear to be fasciculating properly with other axons. If these pioneering axons are unable to form normal fascicles or are unable to coalesce into discrete fascicles, then other later developing neurons may also be expected to have difficulties in fasciculating along their normal pathways. These results suggest that the loss of fru function may very well affect the expression of the specific receptor systems on axons that are necessary to recognize their fasciculation partners (for review, see GOODMAN and DOE 1993 Down; GOODMAN 1996 Down; TEAR 1999 Down; RUSCH and VAN VACTOR 2000 Down). In the dMP2 and vMP2 neurons, the expression of the Futsch protein was also delayed, suggesting that this gene is a target of fru function (HUMMEL et al. 2000 Down). Similar weak labeling of neurons by mab22C10 has also been described in embryos mutant for the argos, pointed, and prospero genes; these genes are known to be important for establishing cell fate and in some cases are required for the formation of FasII axonal tracts (E. SPANA and N. PERRIMON, personal communication; FREEMAN et al. 1992 Down; KLAMBT 1993 Down; SPANA and DOE 1995 Down). There is no direct evidence that the loss of futsch expression in fru mutants leads to abnormalities or delays in the outgrowth of dMP2/vMP2 axons. The UAS-fruA and UAS-fruC transgenes were able to rescue the FasII axonal pattern without rescuing the initial defects in mab22C10 expression in dMP2/vMP2. Thus, it is possible that the defects in axonal outgrowth growth by these neurons depend on alterations in other proteins involved in axonogenesis or axonal pathfinding.

Glial cells have been implicated as important regulators of axonal pathfinding by neurons. Glial cells in the CNS can be grouped into two major categories, midline and the lateral glia, according to their position and gene expression profiles in wild-type embryos. Four segmental midline glial cells, closely associated with the developing commissures, are characterized by the expression of the epidermal growth factor receptor, argos, and pointedP2 (KLAMBT 1993 Down; GIESEN et al. 1997 Down; for reviews, see GRANDERATH and KLAMBT 1999 Down and JACOBS 2000 Down). Lateral glial cells consist of several functional subgroups and express the pointedP1, repo, and glial cell missing genes (KLAMBT 1993 Down; CAMPBELL et al. 1994 Down; XIONG et al. 1994 Down; HALTER et al. 1995 Down; HOSOYA et al. 1995 Down; JONES et al. 1995 Down). Lateral glial cells, identified by their expression of Repo, express Fru proteins. Cell counts in fru mutant embryos revealed no change in the number of Repo-immunoreactive glial cells in these embryos compared with wild type. Likewise, we could find no defects in the number of midline glial cells in fru mutant embryos.

Glial cells of both subtypes are required for the formation of the axonal scaffold of the ventral nerve cord (GIESEN et al. 1997 Down; SCHOLZ et al. 1997 Down; GRANDERATH and KLAMBT 1999 Down; HUMMEL et al. 1999 Down). The loss of lateral glial cells has been implicated in defasciculation phenotypes of tramtrack and glial cells missing mutant embryos (JONES et al. 1995 Down; GIESEN et al. 1997 Down). Defasciculation of FasII axons has also been found in repo mutants in which lateral glial cells are largely present, but are in some way unable to support axonal fasciculation (HALTER et al. 1995 Down; HIDALGO and BOOTH 2000 Down). Other studies have identified mutations in genes involved in midline or glial development causing defects in FasII and BP102 CNS tracts similar to the phenotypes of fru mutants (KLAMBT 1993 Down; GINIGER et al. 1994 Down; SPANA and DOE 1995 Down; GIESEN et al. 1997 Down; SCHOLZ et al. 1997 Down; THOMAS 1998 Down; HUMMEL et al. 1999 Down). The phenotypic similarity between these mutants and fru raises the possibility that fru acts in the same pathway as these other genes in glial cells.

From our findings, we conclude that the fru gene functions in the process of axonal pathfinding by neurons in the embryonic CNS. The earliest neuronal defect that we observed was in the initial outgrowth of axons, which suggests that the fru gene plays an important role in neurons during axonogenesis. Since fru is expressed in neuronal progenitors as well as in neurons and glia, fru may also have a role in cell fate acquisition or maintenance in these cell types.

On the possible function of sex-nonspecific fru transcripts in the adult CNS:
The male-specific Fru proteins derived from the male P1 transcripts are involved in the control of male-specific behaviors (GOODWIN et al. 2000 Down; LEE et al. 2000 Down; USUI-AOKI et al. 2000 Down; LEE and HALL 2001 Down; LEE et al. 2001 Down). fru transcripts from the P2, P3, and P4 promoters are also widely expressed in the CNS and other tissues in the developing males and females, as determined by in situ hybridization with anti-BTB and anti-Com riboprobes (RYNER et al. 1996 Down; M. FOSS and B. J. TAYLOR, personal communication). It seems likely that these fru transcripts might also have the same function in the developing adult CNS as in the embryonic CNS. During metamorphosis, another period of extensive axonogenesis occurs to create the new neuronal circuits needed for adult-specific behaviors. By analogy with the embryonic phase of neuronal differentiation, we anticipate that Fru proteins generated from P2, P3, and/or P4 promoters will be required for the formation of wild-type axonal tracts in the adult CNS.


*  FOOTNOTES

1 Present address: Functional Genomics Department, Novartis Pharmaceuticals, Summit, NJ 07901. Back
2 Present address: Division of Molecular Genetics, University of Glasgow, Glasgow G11 6NU, United Kingdom. Back
3 Present address: Departamento de Genética del Desarrollo, Instituto de Biotecnología, Universidad Nacional Autónoma de México (UNAM), Cuernavaca Morelos 62250, Mexico. Back
4 Present address: Syngenta Biotechnology Inc., Research Triangle Park, NC 27709-2257. Back


*  ACKNOWLEDGMENTS

We thank N. Patel, A. Travers, and J. Skeath for generously supplying us with antibodies and J. C. Hall for critical advice and review. We also thank G. Carney, M. Foss, K. Latham, C. Rivin, T. Dreher, J. Giebultowicz, S. Tornquist, and anonymous reviewers for helpful comments on this work and manuscript. This work was supported by National Institutes of Health grant NS-33352 to B.S.B., J.C.H., and B.J.T. Current financial support to S.F.G., from the Wellcome Trust and Division of Molecular Genetics, University of Glasgow, is gratefully acknowledged. J.-C.B. is supported by a University of Glasgow postgraduate scholarship and an Overseas Research Studentship award.

Manuscript received January 14, 2002; Accepted for publication September 19, 2002.


*  LITERATURE CITED
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

ANAND, A., A. VILLELLA, L. C. RYNER, T. CARLO, and S. F. GOODWIN et al., 2001  Molecular genetic dissection of the sex-specific and vital functions of the Drosophila melanogaster sex determination gene fruitless. Genetics 158:1569-1595.[Abstract/Free Full Text]

BAINBRIDGE, S. P. and M. BOWNES, 1981  Staging the metamorphosis of Drosophila melanogaster. J. Embryol. Exp. Morphol. 66:57-80.[Medline]

BAYER, C. A., L. VON KALM, and J. W. FRISTROM, 1997  Relationships between protein isoforms and genetic functions demonstrate functional redundancy at the Broad-Complex during Drosophila metamorphosis. Dev. Biol. 187:267-282.[Medline]

BRAND, A. H. and N. PERRIMON, 1993  Targeted gene expression as a means of altering cell fate and generating dominant phenotypes. Development 118:401-415.[Abstract]

BROADUS, J. and C. Q. DOE, 1995  Evolution of neuroblast identity: seven-up and prospero expression reveal homologous and divergent neuroblast fates in Drosophila and Schistocerca. Development 121:3989-3996.[Abstract]

BROADUS, J., J. B. SKEATH, E. P. SPANA, T. BOSSING, and G. TECHNAU et al., 1995  New neuroblast markers and the origin of the aCC/pCC neurons in the Drosophila central nervous system. Mech. Dev. 53:393-402.[Medline]

BROSE, K. and M. TESSIER-LAVIGNE, 2000  Slit proteins: key regulators of axon guidance, axonal branching, and cell migration. Curr. Opin. Neurobiol. 10:95-102.[Medline]

CAMPBELL, G., H. GÖRING, T. LIN, E. SPANA, and S. ANDERSSON et al., 1994  RK2, a glial-specific homeodomain protein required for embryonic nerve cord condensation and viability in Drosophila. Development 120:2957-2966.[Abstract]

CAMPOS-ORTEGA, J. A., and V. HARTENSTEIN, 1997 The Embryonic Development of Drosophila melanogaster. Ed. 2. Springer-Verlag, New York.

CASTRILLON, D. H., P. GONZY, S. ALEXANDER, R. RAWSON, and C. G. EBERHART et al., 1993  Toward a molecular genetic analysis of spermatogenesis in Drosophila melanogaster: characterization of male-sterile mutants generated by single P-element mutagenesis. Genetics 135:489-505.[Abstract]

DIBELLO, P. R., D. A. WITHERS, C. A. BAYER, J. W. FRISTROM, and G. M. GUILD, 1991  The Drosophila Broad-Complex encodes a family of related proteins containing zinc fingers. Genetics 129:385-397.[Abstract]

FLYBASE,, 1999  The FlyBase database of the Drosophila genome projects and community literature. Nucleic Acids Res. 27:85-88. http://flybase.bio.indiana.edu/(.[Abstract/Free Full Text]

FREEMAN, M., C. KLÄMBT, C. S. GOODMAN, and G. M. RUBIN, 1992  The argos gene encodes a diffusible factor that regulates cell fate decision in the Drosophila eye. Cell 69:963-975.[Medline]

FUJITA, S. C., S. L. ZIPURSKY, S. BENZER, A. FERRUS, and S. W. SHOTWELL, 1982  Monoclonal antibodies against the Drosophila nervous system. Proc. Natl. Acad. Sci. USA 79:7929-7933.[Abstract/Free Full Text]

GIESEN, K., T. HUMMEL, A. STOLLEWERK, S. HARRISON, and A. TRAVERS et al., 1997  Glial development in the Drosophila CNS requires concomitant activation of glial and repression of neuronal differentiation genes. Development 124:2307-2316.[Abstract]

GINIGER, E., K. TIETJE, L. Y. JAN, and Y. N. JAN, 1994  lola encodes a putative transcription factor required for axon growth and guidance in Drosophila. Development 120:1385-1398.[Abstract]

GOODMAN, C. S., 1996  Mechanisms and molecules that control growth cone guidance. Annu. Rev. Neurosci. 19:341-377.[Medline]

GOODMAN, C. S., and C. Q. DOE, 1993 Embryonic development of the Drosophila central nerve system, pp. 1131–1206 in Development of Drosophila melanogaster, edited by M. BATE and A. MARTINEZ-ARIAS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

GOODWIN, S. F., B. J. TAYLOR, A. VILLELLA, M. FOSS, and L. C. RYNER et al., 2000  Aberrant splicing and altered spatial expression patterns in fruitless mutants of Drosophila melanogaster. Genetics 154:725-745.[Abstract/Free Full Text]

GRANDERATH, S. and C. KLÄMBT, 1999  Glia development in the embryonic CNS of Drosophila. Curr. Opin. Neurobiol. 9:531-536.[Medline]

GRENNINGLOH, G., E. J. REHM, and C. S. GOODMAN, 1991  Genetic analysis of growth cone guidance in Drosophila: fasciclin II functions as a neuronal recognition molecule. Cell 67:45-57.[Medline]

GUTHRIE, S., 1999  Axon guidance: starting and stopping with slit. Curr. Biol. 9:R432-R435.[Medline]

HALTER, D. A., J. URBAN, C. RICKERT, S. S. NER, and K. ITO et al., 1995  The homeobox gene repo is required for the differentiation and maintaince of glia function in the embryonic nervous system of Drosophila melanogaster. Development 121:317-332.[Abstract]

HEINRICHS, V., L. C. RYNER, and B. S. BAKER, 1998  Regulation of sex-specific selection of fruitless 5' splice sites by transformer and transformer-2. Mol. Cell. Biol. 18:450-458.[Abstract/Free Full Text]

HIDALGO, A. and G. E. BOOTH, 2000  Glia dictate pioneer axon trajectories in the Drosophila embryonic CNS. Development 127:393-402.[Abstract]

HIDALGO, A. and A. H. BRAND, 1997  Targeted neuronal ablation: the role of pioneer neurons in guidance and fasciculation in the CNS of Drosophila. Development 124:3253-3262.[Abstract]

HOSOYA, T., K. TAKIZAWA, K. NITTA, and Y. HOTTA, 1995  glial cells missing: a binary switch between neuronal and glial determination in Drosophila. Cell 82:1025-1036.[Medline]

HUMMEL, T., K. SCHIMMELPFENG, and C. KLÄMBT, 1999  Commissure formation in the embryonic CNS of Drosophila. II. Function of the different midline cells. Development 126:771-779.[Abstract]

HUMMEL, T., K. KRUKKERT, J. ROOS, G. DAVIS, and C. KLÄMBT, 2000  Drosophila futsch/22C10 is a MAP1B-like protein required for dendritic and axonal development. Neuron 26:357-370.[Medline]

ITO, H., K. FUJITANI, K. USUI, K. SHIMIZU-NISHIKAWA, and S. TANAKA et al., 1996  Sexual orientation in Drosophila is altered by the satori mutation in the sex determination gene fruitless that encodes a Zinc finger protein with a BTB domain. Proc. Natl. Acad. Sci. USA 93:9687-9692.[Abstract/Free Full Text]

JACOBS, J. R., 2000  The midline glia of Drosophila: a molecular genetic model for the developmental function of glia. Prog. Neurobiol. 62:475-508.[Medline]

JONES, B. W., R. J. FETTER, G. TEAR, and C. S. GOODMAN, 1995  glial cells missing: a genetic switch that controls glial versus neuronal fate. Cell 82:1013-1023.[Medline]

KLAES, A., T. MENNE, A. STOLLEWERK, H. SCHOLZ, and C. KLÄMBT, 1994  The Ets transcription factors encoded by the Drosophila gene pointed direct glial cell differentiation in the embryonic CNS. Cell 78:149-160.[Medline]

KLÄMBT, C., 1993  The Drosophila gene pointed encodes two ETS-like proteins, which are involved in the development of the midline glial cells. Development 117:163-176.[Abstract/Free Full Text]

KRUEGER, N. X., D. VAN VACTOR, H. I. WAN, W. M. GELBART, and C. S. GOODMAN et al., 1996  The transmembrane tyrosine phosphatase DLAR controls motor axon guidance in Drosophila. Cell 84:611-622.[Medline]

LEE, G. and J. C. HALL, 2001  Abnormalities of male-specific FRU protein and serotonin expression in the central nervous system of fruitless mutants in Drosophila. J. Neurosci. 21:513-526.[Abstract/Free Full Text]

LEE, G., M. FOSS, S. F. GOODWIN, T. CARLO, and B. J. TAYLOR et al., 2000  Spatial, temporal, and sexually dimorphic expression patterns of the fruitless gene in the Drosophila central nervous system. J. Neurobiol. 43:404-426.[Medline]

LEE, G., A. VILLELLA, B. J. TAYLOR, and J. C. HALL, 2001  New reproductive anomalies in fruitless-mutant Drosophila males: extreme lengthening of mating durations and infertility correlated with defective serotonergic innervation of reproductive organs. J. Neurobiol. 47:121-149.[Medline]

LIN, D. M. and C. S. GOODMAN, 1994  Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron 13:507-523.[Medline]

LIN, D. M., R. D. FETTER, C. KOPCZYNSKI, G. GRENNINGLOH, and C. S. GOODMAN, 1994  Genetic analysis of Fasciclin II in Drosophila: defasciculation, refasciculation, and altered fasciculation. Neuron 13:1055-1069.[Medline]

O'NEILL, E. M., I. REBAY, R. TIJAN, and G. M. RUBIN, 1994  The activities of two Ets-related transcription factors requred for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell 78:137-147.[Medline]

PATEL, N. H., 1994 Imaging neuronal subsets and other cell types in whole-mount Drosophila embryos and larvae using antibody probes, pp. 445–487 in Drosophila melanogaster: Practical Uses in Cell and Molecular Biology, edited by L. S. B. GOLDSTEIN and E. A. FRYBERG. Academic Press, San Diego.

PATEL, N. H., E. MARTIN-BLANCO, K. G. COLEMAN, S. J. POOLE, and M. C. ELLIS et al., 1989  Expression of engrailed proteins in arthropods, annelids, and chordates. Cell 58:955-968.[Medline]

RESTIFO, L. L. and W. HAUGLUM, 1998  Parallel molecular genetic pathways operate during CNS metamorphosis in Drosophila. Mol. Cell. Neurosci. 11:134-148.[Medline]

RESTIFO, L. L. and V. K. MERRILL, 1994  Two Drosophila regulatory genes, deformed and the Broad-Complex, share common functions in development of adult CNS, head, and salivary glands. Dev. Biol. 162:465-485.[Medline]

ROBERTSON, H. M., C. R. PRESTON, R. W. PHILLIS, D. M. JOHNSON-SCHLITZ, and W. K. BENZ et al., 1988  A stable genomic source of P element transposase in Drosophila melanogaster. Genetics 118:461-470.[Abstract/Free Full Text]

RUBIN, G. M. and A. C. SPRADLING, 1982  Genetic transformation of Drosophila with transposable element vectors. Science 218:348-353.[Abstract/Free Full Text]

RUSCH, J. and D. VAN VACTOR, 2000  New Roundabouts send axons into the Fas lane. Neuron 28:637-640.[Medline]

RYNER, L. C., S. F. GOODWIN, D. H. CASTRILLON, A. ANAND, and A. VILLELLA et al., 1996  Control of male sexual behavior and sexual orientation in Drosophila by the fruitless gene. Cell 87:1079-1089.[Medline]

SANDSTROM, D. J., C. A. BAYER, J. W. FRISTROM, and L. L. RESTIFO, 1997  Broad-Complex transcription factors regulate muscle attachment in Drosophila. Dev. Biol. 181:168-185.[Medline]

SCHOLZ, H., E. SADLOWSKI, A. KLAES, and C. KLÄMBT, 1997  Control of midline glia development in the embryonic Drosophila CNS. Mech. Dev. 64:137-151.[Medline]

SEEGER, M., G. TEAR, D. FERRES-MARCO, and C. S. GOODMAN, 1993  Mutations affecting growth cone guidance in Drosophila: genes necessary for guidance towards or away from the midline. Neuron 10:409-426.[Medline]

SMITH, D. B., 1993  Purification of glutathione-S-transferase fusion proteins. Methods Mol. Cell. Biol. 4:220-229.

SPANA, E. P. and C. Q. DOE, 1995  The prospero transcription factor is asymmetrically localized to the cell cortex during neuroblast mitosis in Drosophila. Development 121:3187-3195.[Abstract]

SPANA, E. P. and C. Q. DOE, 1996  Numb antagonizes Notch signaling to specify sibling neuron cell fates. Neuron 17:21-26.[Medline]

SPANA, E. P., C. KOPCZYNSKI, C. S. GOODMAN, and C. Q. DOE, 1995  Asymmetric localization of numb autonomously determines sibling neuron identity in the Drosophila CNS. Development 121:3489-3494.[Abstract]

SPRADLING, A. C., D. STERN, A. BEATON, E. J. RHEM, and T. LAVERTY et al., 1999  The Berkeley Drosophila Genome Project gene disruption project: single P-element insertions mutating 25% of vital Drosophila genes. Genetics 153:135-177.[Abstract/Free Full Text]

SUN, Q., S. BAHRI, A. SCHMID, W. CHIA, and K. ZINN, 2000  Receptor tyrosine phosphatases regulate axon guidance across the midline of the Drosophila embryo. Development 127:801-812.[Abstract]

TEAR, G., 1999  Neuronal guidance. A genetic perspective. Trends Genet. 15:113-118.[Medline]

THOMAS, J. B., 1998  Axon guidance: crossing the midline. Curr. Biol. 8:R102-R104.[Medline]

USUI-AOKI, K., H. ITO, K. UI-TEI, K. TAKAHASHI, and T. LUKACSOVICH et al., 2000  Formation of the male-specific muscle in female Drosophila by ectopic fruitless expression. Nat. Cell Biol. 2:500-506.[Medline]

VAN ROESSEL, P., and A. H. BRAND, 2000 GAL4-mediated ectopic gene expression in Drosophila, pp 439–447 in Drosophila Protocols, edited by W. SULLIVAN, M. ASHBURNER and R. S. HAWLEY. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

VILLELLA, A., D. A. GAILEY, B. BERWALD, S. OHSHIMA, and P. T. BARNES et al., 1997  Extended reproductive roles of the fruitless gene in Drosophila melanogaster revealed by behavioral analysis of new fru mutants. Genetics 147:1107-1130.[Abstract]

XIONG, W.-C., H. OKANO, N. H. PATEL, J. A. BLENDY, and C. MONTELL, 1994  repo encodes a glial-specific homeodomain protein required in the Drosophila nervous system. Genes Dev. 8:981-994.[Abstract/Free Full Text]

YEO, S. L., A. LLOYD, K. KOZAK, A. DINH, and T. DICK et al., 1995  On the functional overlap between two Drosophila POU homeodomain genes and the cell fate specification of a CNS neural precursor. Genes Dev. 9:1223-1236.[Abstract/Free Full Text]

ZOLLMAN, S., D. GODT, G. G. PRIVE, J. L. COUDERC, and F. A. LASKI, 1994  The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc. Natl. Acad. Sci. USA 91:10717-10721.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Mol Biol EvolHome page
R. C. Bertossa, L. van de Zande, and L. W. Beukeboom
The Fruitless Gene in Nasonia Displays Complex Sex-Specific Splicing and Contains New Zinc Finger Domains
Mol. Biol. Evol., July 1, 2009; 26(7): 1557 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
D. A. Gailey, J.-C. Billeter, J. H. Liu, F. Bauzon, J. B. Allendorfer, and S. F. Goodwin
Functional Conservation of the fruitless Male Sex-Determination Gene Across 250 Myr of Insect Evolution
Mol. Biol. Evol., March 1, 2006; 23(3): 633 - 643.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
L. M. Ditch, T. Shirangi, J. L. Pitman, K. L. Latham, K. D. Finley, P. T. Edeen, B. J. Taylor, and M. McKeown
Drosophila retained/dead ringer is necessary for neuronal pathfinding, female receptivity and repression of fruitless independent male courtship behaviors
Development, January 1, 2005; 132(1): 155 - 164.
[Abstract] [Full Text] [PDF]